XML 31 R13.htm IDEA: XBRL DOCUMENT v3.3.1.900
Stockholders' Equity
12 Months Ended
Dec. 31, 2015
Stockholders Equity Note [Abstract]  
Stockholders' Equity
7. Stockholders’ Equity
 
Common stock
 
The Company is authorized to issue up to 110,000,000 shares, of which 100,000,000 shares have been designated as common stock and 10,000,000 shares as preferred stock. Holders of the Company's common stock are entitled to dividends if and when declared by the Board of Directors. The holders of each share of common stock shall have the right to one vote for each share and are entitled, as a share class, to elect two directors of the Company.
 
On March 31, 2015, the Company entered into a securities purchase agreement (“Purchase Agreement”) with certain investors (the “Purchasers”) pursuant to which the Company sold 467,392 shares of its common stock (the “Shares”) at a purchase price of $4.60 per share resulting in gross proceeds to the Company of $2.15 million (the “Registered Direct Offering”). The Registered Direct Offering was effected as a takedown off the Company’s shelf registration statement on Form S-3 (File No. 333-199647), which was declared effective on November 10, 2014, and a related prospectus supplement to be filed on April 2, 2015 in connection with the Registered Direct Offering. The Registered Direct Offering closed on April 6, 2015.
 
In connection with the Registered Direct Offering, the Company entered into a placement agent agreement (the “Placement Agent Agreement”) with Ladenburg Thalmann & Co. Inc. (the “Placement Agent”) to act as its exclusive placement agent. Pursuant to the Placement Agent Agreement, the Company paid to the Placement Agent $106,000 in cash, issued to the Placement Agent 5,762 five-year warrants with an exercise price of $5.75 per share (the “RD Warrants”) and reimbursed the Placement Agent for certain expenses. In addition, the Company paid to Laidlaw & Company (UK) Ltd. $50,000 in cash and issued 10,870 RD Warrants in connection with certain tail fees owed to them as a result of the Registered Direct Offering. The RD Warrants allow for cashless exercise in certain situations and contain piggyback registration rights for the seven year period commencing on March 31, 2015.
 
In addition, the Placement Agent will also be entitled to a tail fee if, within twelve months after the termination of expiration of the Placement Agent Agreement, the Company sells securities to any investor that was introduced to the Company by the Placement Agent and purchased shares in the Registered Direct Offering. The tail fee will be the same as the placement agent’s fee received by the Placement Agent in the Registered Direct Offering, subject to certain reductions described in the Placement Agent Agreement.
 
In connection with the Registered Direct Offering, the Company entered into a separate waiver agreement with one of its current stockholders pursuant to which the holder waived its right of participation to participate in the Registered Direct Offering (the “Right of Participation”). In consideration for such waiver, the Company paid to the holder $35,000 in cash and waived any trading volume limitations or other lock-up provisions or restrictions imposed on the holder pursuant to an existing securities purchase agreement and an existing lock-up agreement the holder entered into with the Company. The Company also agreed that in the event that the Company obtains a consent, release amendment, settlement or waiver of the Right of Participation from any other stockholder holding such right in connection with the Registered Direct Offering on more favorable terms than in the waiver agreement prior to expiration of the Right of Participation of the holder, the holder will be entitled to the benefit of the more favorable terms. The holder’s Right of Participation terminated on September 8, 2015.
 
Shares of common stock reserved for future issuance were as follows as of December 31, 2015:
 
Options to purchase common stock
 
 
369,887
 
Shares reserved for issuances pursuant to 2014 Stock Plan
 
 
71,431
 
Warrants
 
 
179,567
 
Total
 
 
620,885
 
 
Convertible preferred stock
 
Convertible preferred stock as of December 31, 2015 consisted of the following:
 
 
 
 
 
 
 
Shares
 
 
 
 
 
Convertible
 
Original
 
Shares
 
Originally
 
Shares
 
Liquidation
 
Preferred Stock
 
Issue Price
 
Designated
 
Issued
 
Outstanding
 
Preference
 
Series A-1
 
$
0.0100
 
 
5,000,000
 
 
5,000,000
 
 
0
 
$
-
 
Series A-2
 
$
1.6996
 
 
1,176,748
 
 
1,176,748
 
 
0
 
$
-
 
Series B
 
$
1,000.00
 
 
2,750
 
 
2,750
 
 
0
 
$
-
 
 
In October 2015, the Company entered into agreements with holders of all of the outstanding Series A and Series B Preferred Stock pursuant to which the holders agreed to exchange all of their outstanding shares of Series A and Series B Preferred Stock for common stock. As a result, as of December 31, 2015, there were no remaining shares of Series A or Series B Preferred Stock outstanding. The previously-outstanding Preferred Stock amounts, along with the newly-issued common stock amounts, are as follows:
 
 
 
Outstanding as of Sept. 30, 2015
 
Newly-Issued Common Stock
 
Series A-1
 
 
212,466
 
 
141,262
 
Series A-2
 
 
161,355
 
 
28,518
 
Series B
 
 
1,102
 
 
420,956
 
 
Warrants
 
In January 2014, the Company issued warrants to purchase 23,858 shares of common stock at an exercise price of $30.40 to a placement agent. The warrants expire in January 2019. The exercise price was reduced to its floor of $22.70 as a result of the sale of the Fortress Shares. The warrants may be exercised without cash consideration in lieu of forfeiting a portion of shares. The fair value of the warrants at issuance was $348,963, estimated using the Black-Scholes option pricing model. The fair value of the warrants was revalued at December 31, 2015 as discussed in Note 5.
 
On November 1, 2014 the Company issued 27,750 warrants to purchase common stock with a weighted average exercise price of $20.70. The fair value of the warrants at issuance was $164,196.
 
Common stock warrants outstanding as of December 31, 2015 are listed as follows:
 
Warrants
 
Remaining Contractual
 
Weighted Average
 
Outstanding
 
Life (years)
 
Exercise
 
 
50,000
 
 
6.17
 
$
2.54
 
 
10,870
 
 
4.27
 
$
4.60
 
 
5,762
 
 
4.27
 
$
5.75
 
 
2,699
 
 
4.16
 
$
20.00
 
 
24,750
 
 
3.84
 
$
20.00
 
 
23,858
 
 
3.08
 
$
22.70
 
 
58,628
 
 
0.50
 
$
26.60
 
 
3,000
 
 
1.84
 
$
26.60
 
 
179,567
 
 
3.31
 
$
16.37